Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks.
Yarava A, Marshall C, Reichert DE, Ye A, Khanal P, Robbins SH, Sachais BS, Oh D, Metcalf RA, Conry-Cantilena K, King K, Reyes M, Adamski J, Marques MB, Tran MH, Allen ES, Pach D, Blumberg N, Hobbs R, Nash T, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Rausch W, Oei K, Abinante M, Forthal DN, Zand MS, Kassaye SG, Cachay ER, Gebo KA, Shoham S, Casadevall A, McBee NA, Amirault D, Wang Y, Hopkins E, Shade DM, Layendecker O, Klein SL, Park HS, Lee JS, Caturegli P, Raval JS, Cruser D, Ziman AF, Gerber J, Gniadek TJ, Bloch EM, Tobian AAR, Hanley DF, Sullivan DJ, Lane K; CSSC (COVID 19 Serologic Studies Consortium) group. Yarava A, et al. Among authors: casadevall a. J Clin Transl Sci. 2024 Nov 14;8(1):e200. doi: 10.1017/cts.2024.642. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39655012 Free PMC article.
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2.
Natarajan H, Xu S, Crowley AR, Butler SE, Weiner JA, Bloch EM, Littlefield K, Benner SE, Shrestha R, Ajayi O, Wieland-Alter W, Sullivan D, Shoham S, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR, Connor RI, Wright PF, Ackerman ME. Natarajan H, et al. Among authors: casadevall a. medRxiv [Preprint]. 2021 Aug 8:2021.08.06.21261710. doi: 10.1101/2021.08.06.21261710. medRxiv. 2021. Update in: BMC Immunol. 2022 Feb 16;23(1):7. doi: 10.1186/s12865-022-00480-w PMID: 34401890 Free PMC article. Updated. Preprint.
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.
Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D. Shoham S, et al. Among authors: casadevall a. medRxiv [Preprint]. 2021 Dec 14:2021.12.13.21267611. doi: 10.1101/2021.12.13.21267611. medRxiv. 2021. Update in: Clin Infect Dis. 2023 Feb 8;76(3):e477-e486. doi: 10.1093/cid/ciac372 PMID: 34931202 Free PMC article. Updated. Preprint.
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Sullivan DJ, et al. Among authors: casadevall a. medRxiv [Preprint]. 2021 Dec 21:2021.12.10.21267485. doi: 10.1101/2021.12.10.21267485. medRxiv. 2021. PMID: 34981068 Free PMC article. Preprint.
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern.
Li M, Beck EJ, Laeyendecker O, Eby Y, Tobian AA, Caturegli P, Wouters C, Chiklis GR, Block W, McKie R, Joyner M, Wiltshire TD, Dietz AB, Gniadek TJ, Shapiro A, Yarava A, Lane K, Hanley D, Bloch EM, Shoham S, Cachay ER, Meisenberg BR, Huaman MA, Fukuta Y, Patel B, Heath SL, Levine AC, Paxton JH, Anjan S, Gerber JM, Gebo KA, Casadevall A, Pekosz A, Sullivan DJ; CSSC group. Li M, et al. Among authors: casadevall a. medRxiv [Preprint]. 2022 Mar 2:2022.03.01.22271662. doi: 10.1101/2022.03.01.22271662. medRxiv. 2022. Update in: Blood Adv. 2022 Jun 28;6(12):3678-3683. doi: 10.1182/bloodadvances.2022007410 PMID: 35262085 Free PMC article. Updated. Preprint.
Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources.
Sullivan DJ, Franchini M, Joyner MJ, Casadevall A, Focosi D. Sullivan DJ, et al. Among authors: casadevall a. medRxiv [Preprint]. 2022 Aug 22:2021.12.24.21268317. doi: 10.1101/2021.12.24.21268317. medRxiv. 2022. Update in: Nat Commun. 2022 Oct 29;13(1):6478. doi: 10.1038/s41467-022-33864-y PMID: 35982681 Free PMC article. Updated. Preprint.
Early Treatment, Inflammation and Post-COVID Conditions.
Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Casadevall A, Bloch EM, Hanley D, Tobian AAR, Sullivan DJ. Gebo KA, et al. Among authors: casadevall a. medRxiv [Preprint]. 2023 Feb 16:2023.02.13.23285855. doi: 10.1101/2023.02.13.23285855. medRxiv. 2023. PMID: 36824860 Free PMC article. Preprint.
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
Park HS, Yin A, Barranta C, Lee JS, Caputo CA, Sachithanandham J, Li M, Yoon S, Sitaras I, Jedlicka A, Eby Y, Ram M, Fernandez RE, Baker OR, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Lau B, Ehrhardt S, Baksh SN, Shapiro JR, Ou J, Na YB, Knoll MD, Ornelas-Gatdula E, Arroyo-Curras N, Gniadek TJ, Caturegli P, Wu J, Ndahiro N, Betenbaugh MJ, Ziman A, Hanley DF, Casadevall A, Shoham S, Bloch EM, Gebo KA, Tobian AAR, Laeyendecker O, Pekosz A, Klein SL, Sullivan DJ. Park HS, et al. Among authors: casadevall a. medRxiv [Preprint]. 2023 Dec 15:2023.04.13.23288353. doi: 10.1101/2023.04.13.23288353. medRxiv. 2023. Update in: JCI Insight. 2024 Mar 14;9(8):e178460. doi: 10.1172/jci.insight.178460 PMID: 37131659 Free PMC article. Updated. Preprint.
Convalescent Plasma for Covid-19-Induced ARDS.
Casadevall A, Shoham S, Pirofski LA. Casadevall A, et al. N Engl J Med. 2024 Jan 25;390(4):385-386. doi: 10.1056/NEJMc2313675. N Engl J Med. 2024. PMID: 38265661 No abstract available.
1,107 results